Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles (2018 - 2026)

Rocket Pharmaceuticals (RCKT) has 9 years of Goodwill & Intangibles data on file, last reported at $64.3 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles changed 0.07% year-over-year to $64.3 million; the trailing twelve-month figure through Mar 2026 stood at $64.3 million (changed 0.07% YoY), and the FY2025 full-year result was $64.4 million, changed 0.0% from the prior year.
• Goodwill & Intangibles was little changed at $64.3 million in Q1 2026, from $64.4 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $64.9 million in Q4 2022 to a low of $30.8 million in Q1 2022.
• A 5-year average of $58.5 million and a median of $64.4 million in 2023 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles jumped 110.69% in 2022 and fell 0.88% in 2024, its largest moves.
• Tracing RCKT's Goodwill & Intangibles over 5 years: stood at $64.9 million in 2022, then slipped by 0.88% to $64.4 million in 2023, then changed by 0.0% to $64.4 million in 2024, then changed by 0.0% to $64.4 million in 2025, then fell by 0.07% to $64.3 million in 2026.
• Business Quant data shows RCKT's Goodwill & Intangibles at $64.3 million in Q1 2026, $64.4 million in Q4 2025, and $64.4 million in Q3 2025.